SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-163546
Filing Date
2023-06-08
Accepted
2023-06-08 16:31:00
Documents
16
Period of Report
2023-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d518843d8k.htm   iXBRL 8-K 28187
2 EX-1.1 d518843dex11.htm EX-1.1 182578
3 EX-5.1 d518843dex51.htm EX-5.1 6486
7 GRAPHIC g518843g30e71.jpg GRAPHIC 8065
8 GRAPHIC g518843g67p74.jpg GRAPHIC 6480
  Complete submission text file 0001193125-23-163546.txt   416109

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cogt-20230606.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20230606_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20230606_pre.xml EX-101.PRE 11711
10 EXTRACTED XBRL INSTANCE DOCUMENT d518843d8k_htm.xml XML 3455
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 231002356
SIC: 2834 Pharmaceutical Preparations